Carlsmed (CARL) Return on Sales (2024 - 2026)

Carlsmed (CARL) reported Return on Sales of 0.01% for Q1 2026, little changed on a YoY basis from 0.01% in Q1 2025, and up 5.07% quarter-over-quarter from 0.01% in Q4 2025.

Carlsmed (CARL) Return on Sales (2024 - 2026) Analysis & Trends

Carlsmed has reported Return on Sales for 3 years, with the latest figure at 0.01% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
  • Return on Sales for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
  • The five-year high for Return on Sales was 0.0% in Q4 2024, with the low at 0.01% in Q3 2024.
  • Historically, Return on Sales has averaged 0.01% across 3 years, with a median of 0.01% in 2025.
  • The largest YoY upside for Return on Sales was 1 bps in 2025 against a maximum downside of 0 bps in 2025.
  • Carlsmed's Return on Sales stood at 0.0% in 2024, then decreased by 15 bps to 0.01% in 2025, then rose by 5 bps to 0.01% in 2026.
  • The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 0.00%
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 0.00%
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 0.00%
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 0.00%
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 0.00%
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 0.00%
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 0.00%
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 0.00%
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 0.00%
10 Carlsmed 265.54 Mn 168.34 Mn 12.43 Mn -0.01%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.01%
Dec 31, 2025 -0.01%
Sep 30, 2025 -0.01%
Jun 30, 2025 -0.01%
Mar 31, 2025 -0.01%
Dec 31, 2024 0.00%
Sep 30, 2024 -0.01%
Jun 30, 2024 -0.01%